# SwitchPoint Bio Holding, Inc. — Form D

SwitchPoint Bio Holding, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-10. The offering totals $5.3M, of which $5.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-03-10
- Form: D
- Accession: 0002113353-26-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $5.3M
- Amount sold: $5.3M
- Investors: 6
- Date of first sale: 2026-03-09
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-576064

## Issuer

- Name: SwitchPoint Bio Holding, Inc.
- CIK: 0002113353
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 251 LITTLE FALLS DRIVE, WILMINGTON, DE, 19808
- Phone: 6509969693

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Samuel Myllykangas | Director | Espoo, H9 |
| Jussi Paananen | Director | Helsinki, H9 |
| David Proctor | Director | Austin, TX |
| Samuel Myllykangas | Executive Officer | Espoo, H9 |
| Jussi Paananen | Executive Officer | Helsinki, H9 |

## More

- [CIK 2113353 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2113353&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002113353-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.